Evidence map›Paper›PMID 33520985›Full record

ReviewFrontiers in cell and developmental biology2020

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.

Franz Ewendt, Martina Feger, Michael Föller

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07113418 (Role of Fibroblast Growth Factor 21), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07113418 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Role of Fibroblast Growth Factor 21(FGF21) in Breast Cancer

Typeobservational_patient_registrySponsorAssiut UniversityRan2025 to 2026Enrolled84ConditionsBreast CancerArmsELISA
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Current and novel biomarkers in cardiogenic shock.European journal of heart failure · 2025
    Review
  5. Article
  6. The vitamin DAmerican journal of physiology. Cell physiology · 2025
    Article
  7. Emerging concepts on the FGF23 regulation and activity.Molecular and cellular biochemistry · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. PKC regulates αKlotho gene expression in MDCK and NRK-52E cells.Pflugers Archiv : European journal of physiology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Franz EwendtDepartment of Nutritional Physiology, Institute of Agricultural and Nutritional Sciences, Martin-Luther University Halle-Wittenberg, Halle, Germany.
Martina FegerDepartment of Physiology, University of Hohenheim, Stuttgart, Germany.
Michael FöllerDepartment of Physiology, University of Hohenheim, Stuttgart, Germany.
University of Hohenheim · DEMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Together with fibroblast growth factors (FGFs) 19 and 21, FGF23 is an endocrine member of the family of FGFs. Mainly secreted by bone cells, FGF23 acts as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)

Indexed as

Ca2+calcitriolinflammationmalignanciesphosphate

Identifiers

PMID33520985
PMCPMC7841205
OpenAlexW3118367938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.